New FDA-Approved Diabetes Drug Slashes Heart Attack and Stroke Risk
Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...
Daily20 小时
Medical Bulletin 22/ February/ 2025 - Video
Workplace Bullying's Sleep Impact Spreads to Partners, reveals studyWorkplace bullying affects not only the employee’s sleep ...
Lancet GH丨滕皋军院士团队：肝细胞癌局部联合系统治疗前沿及展望
为探索验证该联合治疗疗效并组织发起系列高质量研究，“中国肝癌临床研究联盟（CHANCE）”于2021年成立。目前，CHANCE已发起在研三十多项关于TACE联合免疫治疗的临床研究，其中CHANCE001、CHANCE2211、CHANCE2201等多 ...